MENOGON FERTI-M FERTI-M FOLINIS FOLINIS

Dose: 75 to 300 IU
Single Dose: 190 (187.5)
Frequency: 24 hourly
Route: IM
Instructions: Followed by 5000-10,000U 1 day after the last dose.

Dose: Not use in children
Single Dose:
Frequency:
Route:
Instructions:

Dose: Not indicated in this age group
Single Dose:
Frequency:
Route:
Instructions:

. It is of Natural origin and belongs to Steroid. It belongs to Sex Hormones and Gonadotropin, Ovulation Stimulator pharmacological group.The Molecular Weight of Menotrophin is 36.00.

Menotrophin is contraindicated in conditions like Testicular tumors,Ovarian dysgenesis,Premature menopause,Tubal disease,Testicular failure,Pituitary tumor.

The severe or irreversible adverse effects of Menotrophin, which give rise to further complications include Pulmonary edema, Gynacomastia, Thromboembolism.Menotrophin produces potentially life-threatening effects which include Ovarian hyperstimulation syndrome (OHSS). which are responsible for the discontinuation of Menotrophin therapy.The symptomatic adverse reactions produced by Menotrophin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Tiredness, Headache, Fever, Abdominal pain, Weight gain, Fluid retention, Mood swings, Joint pain.

Menotrophin is primarily indicated in conditions like Cryptorchidism (undescended testes), Follicular growth stimulation, Hypogonadotrophic hypogonadism, Male infertility, Superovulation.

No data regarding the interactions of Menotrophin was found.

Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

IM Inj Store at room temperature, Below 25°C or in refrigerator. Do not Freeze. Protect from Sunlight.

Menotrophin should not be given to the pregnant women and use cautiously in the breast-feeding women.